Technical Analysis for INO - Inovio Pharmaceuticals, Inc.

Grade Last Price % Change Price Change
grade F 3.52 0.00% 0.00
INO closed unchanged on Monday, March 18, 2019, on 57 percent of normal volume.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Down Down Flat
See historical INO trend table...

Date Alert Name Type % Chg
Mar 14 1,2,3 Retracement Bearish Bearish Swing Setup -2.76%
Mar 14 Non-ADX 1,2,3,4 Bearish Bearish Swing Setup -2.76%
Mar 14 Narrow Range Bar Range Contraction -2.76%
Mar 14 NR7 Range Contraction -2.76%
Mar 14 Inside Day Range Contraction -2.76%
Mar 13 Pocket Pivot Bullish Swing Setup -3.56%
Mar 13 Wide Range Bar Range Expansion -3.56%
Mar 13 New 52 Week Low Weakness -3.56%
Mar 13 Earnings Movers Other -3.56%
Mar 13 Outside Day Range Expansion -3.56%

Older signals for INO ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
Inovio Pharmaceuticals, Inc., together with its subsidiaries, engages in the discovery and development of synthetic vaccines and immune therapies focusing on cancers and infectious diseases. The company's DNA-based SynCon technology enables the design of vaccines capable of providing cross-protection against new, unmatched strains of pathogens, such as influenza. Its electroporation DNA delivery technology uses controlled electrical pulses to enhance cellular DNA vaccine uptake. The company's clinical programs include human papillomavirus/cervical cancer (therapeutic), avian influenza (preventive), prostate cancer (therapeutic), leukemia (therapeutic), hepatitis C virus, hepatitis B virus, human immunodeficiency virus, and malaria vaccines. It is also advancing preclinical research for a seasonal/pandemic influenza vaccine, as well as other products. Inovio Pharmaceuticals, Inc. has collaboration and license agreements with VGX International, Merck, and ChronTech. The company was formerly known as Inovio Biomedical Corporation and changed its name to Inovio Pharmaceuticals, Inc. in May 2010. Inovio Pharmaceuticals, Inc. was founded in 1983 and is headquartered in Blue Bell, Pennsylvania.
Medicine Medical Specialties Infectious Diseases Cancers Prostate Cancer Influenza Vaccination Leukemia Vaccines Virus Influenza Vaccine Malaria Virology Seasonal/Pandemic Influenza Universal Flu Vaccine
Is INO a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 4 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 6.3
52 Week Low 3.02
Average Volume 1,361,499
200-Day Moving Average 4.6524
50-Day Moving Average 4.2964
20-Day Moving Average 3.628
10-Day Moving Average 3.531
Average True Range 0.2114
ADX 38.48
+DI 8.4156
-DI 33.8651
Chandelier Exit (Long, 3 ATRs ) 3.3158
Chandelier Exit (Short, 3 ATRs ) 3.6542
Upper Bollinger Band 3.8662
Lower Bollinger Band 3.3898
Percent B (%b) 0.27
BandWidth 13.131202
MACD Line -0.2129
MACD Signal Line -0.245
MACD Histogram 0.0321
Fundamentals Value
Market Cap 317.6 Million
Num Shares 90.2 Million
EPS -1.07
Price-to-Earnings (P/E) Ratio -3.29
Price-to-Sales 9.78
Price-to-Book 3.53
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 3.76
Resistance 3 (R3) 3.76 3.68 3.72
Resistance 2 (R2) 3.68 3.62 3.68 3.71
Resistance 1 (R1) 3.60 3.58 3.56 3.60 3.69
Pivot Point 3.52 3.52 3.50 3.52 3.52
Support 1 (S1) 3.44 3.46 3.40 3.44 3.35
Support 2 (S2) 3.36 3.42 3.36 3.33
Support 3 (S3) 3.28 3.36 3.32
Support 4 (S4) 3.28